Zobrazeno 1 - 10
of 631
pro vyhledávání: '"Liberg, D."'
Autor:
Hansen N; Lund Stem Cell Center, Lund University, Lund, Sweden., Peña-Martínez P; Lund Stem Cell Center, Lund University, Lund, Sweden., Skoog P; Cantargia AB, Lund, Sweden., Reinbach K; Lund Stem Cell Center, Lund University, Lund, Sweden., Hansen FC; Lund Stem Cell Center, Lund University, Lund, Sweden., Faria SL; Truly Labs AB, Lund, Sweden., Grönberg C; Cantargia AB, Lund, Sweden., Abdilleh K; Pancreatic Cancer Action Network, Manhattan Beach, California, USA., Magnusson S; Cantargia AB, Lund, Sweden., von Wachenfeldt K; Truly Labs AB, Lund, Sweden., Millrud CR; Cantargia AB, Lund, Sweden., Liberg D; Cantargia AB, Lund, Sweden., Järås M; Lund Stem Cell Center, Lund University, Lund, Sweden marcus.jaras@med.lu.se.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Dec 18; Vol. 12 (12). Date of Electronic Publication: 2024 Dec 18.
Autor:
Lema DA; Department of Pathology, School of Medicine (D.A.L., D.E., M.V.T., D.Č.), Johns Hopkins University, Baltimore, MD., Jakobsson G; Department of Translational Medicine, Lund University, Malmö, Sweden (G.J., A.S.)., Daoud A; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health (A.D., H.K., D.Č.), Johns Hopkins University, Baltimore, MD., Elias D; Department of Pathology, School of Medicine (D.A.L., D.E., M.V.T., D.Č.), Johns Hopkins University, Baltimore, MD., Talor MV; Department of Pathology, School of Medicine (D.A.L., D.E., M.V.T., D.Č.), Johns Hopkins University, Baltimore, MD., Rattik S; Cantargia AB, Lund, Sweden (S.R., C.G., E.J.G., D.L.)., Grönberg C; Cantargia AB, Lund, Sweden (S.R., C.G., E.J.G., D.L.)., Kalinoski H; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health (A.D., H.K., D.Č.), Johns Hopkins University, Baltimore, MD., Jaensson Gyllenbäck E; Cantargia AB, Lund, Sweden (S.R., C.G., E.J.G., D.L.)., Wang N; Department of Cardiology, School of Medicine (N.W.), Johns Hopkins University, Baltimore, MD., Liberg D; Cantargia AB, Lund, Sweden (S.R., C.G., E.J.G., D.L.)., Schiopu A; Department of Translational Medicine, Lund University, Malmö, Sweden (G.J., A.S.).; Internal Medicine Clinic, Skåne University Hospital, Lund, Sweden (A.S.).; 'Nicolae Simionescu' Institute of Cellular Biology and Pathology, Bucharest, Romania (A.S.)., Čiháková D; Department of Pathology, School of Medicine (D.A.L., D.E., M.V.T., D.Č.), Johns Hopkins University, Baltimore, MD.; W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health (A.D., H.K., D.Č.), Johns Hopkins University, Baltimore, MD.
Publikováno v:
Circulation. Heart failure [Circ Heart Fail] 2024 Dec; Vol. 17 (12), pp. e011729. Date of Electronic Publication: 2024 Nov 08.
Autor:
Grönberg C; Cantargia AB, Lund, Sweden., Rattik S; Cantargia AB, Lund, Sweden., Tran-Manh C; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Zhou X; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Rius Rigau A; Department of Internal Medicine 3, University Hospital Erlangen, Erlangen, Bayern, Germany., Li YN; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Györfi AH; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Dickel N; Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany., Kunz M; Chair of Medical Informatics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany., Kreuter A; Department of Dermatology, Venereology, and Allergology, HELIOS Saint Elisabeth Hospital Oberhausen, University Witten-Herdecke, Oberhausen, Nordrhein-Westfalen, Germany., Matei EA; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Zhu H; Department of Rheumatology, Xiangya Hospital, Central South University, Changsha, Hunan, China., Skoog P; Cantargia AB, Lund, Sweden., Liberg D; Cantargia AB, Lund, Sweden., Distler JH; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany joerg.distler@uk-erlangen.de.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany., Trinh-Minh T; Department of Rheumatology, University Hospital of Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.; Hiller Research Center, University Hospital Düsseldorf, Heinrich-Heine-University, Düsseldorf, NRW, Germany.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Aug 27; Vol. 83 (9), pp. 1156-1168. Date of Electronic Publication: 2024 Aug 27.
Autor:
Fields JK; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Gyllenbäck EJ; Cantargia AB, Lund, Sweden., Bogacz M; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA., Obi J; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Birkedal GS; Cantargia AB, Lund, Sweden., Sjöström K; Innovagen AB, Lund, Sweden., Maravillas K; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA., Grönberg C; Cantargia AB, Lund, Sweden., Rattik S; Cantargia AB, Lund, Sweden., Kihn K; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Flowers M; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA., Smith AK; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Hansen N; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Fioretos T; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Huyhn C; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA., Liberg D; Cantargia AB, Lund, Sweden., Deredge D; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD 21201, USA., Sundberg EJ; Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA. Electronic address: eric.sundberg@emory.edu.
Publikováno v:
Cell reports [Cell Rep] 2024 May 28; Vol. 43 (5), pp. 114099. Date of Electronic Publication: 2024 Apr 17.
Autor:
Mulholland M; Department of Clinical Sciences, Cardiovascular Research-Immune Regulation, Lund University, Malmö, Sweden., Depuydt MAC; Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University, Leiden, The Netherlands., Jakobsson G; Department of Translational Medicine, Cardiac Inflammation, Lund University, Malmö, Sweden., Ljungcrantz I; Department of Clinical Sciences, Cardiovascular Research-Immune Regulation, Lund University, Malmö, Sweden., Grentzmann A; Department of Clinical Sciences, Cardiovascular Research-Immune Regulation, Lund University, Malmö, Sweden., To F; Department of Clinical Sciences, Cardiovascular Research-Matrix and Inflammation in Atherosclerosis, Lund University, Malmö, Sweden., Bengtsson E; Department of Clinical Sciences, Cardiovascular Research-Matrix and Inflammation in Atherosclerosis, Lund University, Malmö, Sweden.; Department of Biomedical Science, Malmö University, Malmö, Sweden.; Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden., Jaensson Gyllenbäck E; Cantargia AB, Lund, Sweden., Grönberg C; Cantargia AB, Lund, Sweden., Rattik S; Department of Clinical Sciences, Cardiovascular Research-Immune Regulation, Lund University, Malmö, Sweden.; Cantargia AB, Lund, Sweden., Liberg D; Cantargia AB, Lund, Sweden., Schiopu A; Department of Translational Medicine, Cardiac Inflammation, Lund University, Malmö, Sweden., Björkbacka H; Department of Clinical Sciences, Cardiovascular Research-Cellular Metabolism and Inflammation, Lund University, Malmö, Sweden., Kuiper J; Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University, Leiden, The Netherlands., Bot I; Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University, Leiden, The Netherlands., Slütter B; Leiden Academic Centre for Drug Research, Division of Biotherapeutics, Leiden University, Leiden, The Netherlands., Engelbertsen D; Department of Clinical Sciences, Cardiovascular Research-Immune Regulation, Lund University, Malmö, Sweden.
Publikováno v:
Cardiovascular research [Cardiovasc Res] 2024 May 07; Vol. 120 (6), pp. 581-595.
Autor:
Robbrecht D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. d.robbrecht@erasmusmc.nl., Jungels C; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Sorensen MM; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Spanggaard I; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Eskens F; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Fretland SØ; Department of Oncology, Oslo University Hospital, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway., Aftimos P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Liberg D; Cantargia, Lund, Sweden., Svedman C; Cantargia, Lund, Sweden., Thorsson L; Cantargia, Lund, Sweden., Steeghs N; Netherlands Cancer Institute, Amsterdam, The Netherlands., Awada A; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Apr; Vol. 126 (7), pp. 1010-1017. Date of Electronic Publication: 2021 Dec 13.
Autor:
Rydberg Millrud C; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden., Deronic A; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden., Grönberg C; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden., Jaensson Gyllenbäck E; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden., von Wachenfeldt K; Truly Labs AB, Medicon Village, 22381, Lund, Sweden., Forsberg G; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden., Liberg D; Cantargia AB, Ideon Gateway, Scheelevägen 27, 22363, Lund, Sweden. david.liberg@cantargia.com.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Mar; Vol. 72 (3), pp. 667-678. Date of Electronic Publication: 2022 Aug 29.
Publikováno v:
British Journal of Cancer. 11/15/99, Vol. 81 Issue 6, p981. 8p.
Autor:
Fields JK; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.; Program in Molecular Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States., Kihn K; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, United States., Birkedal GS; Cantargia AB, Lund, Sweden., Klontz EH; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.; Program in Molecular Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States., Sjöström K; Innovagen AB, Lund, Sweden., Günther S; Center for Free-Electron Laser Science, Deutsches Elektronen-Synchrotron (DESY), Hamburg, Germany., Beadenkopf R; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States., Forsberg G; Cantargia AB, Lund, Sweden., Liberg D; Cantargia AB, Lund, Sweden., Snyder GA; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.; Department of Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, MD, United States., Deredge D; Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, United States., Sundberg EJ; Department of Biochemistry, Emory School of Medicine, Atlanta, GA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2021 Dec 24; Vol. 12, pp. 779100. Date of Electronic Publication: 2021 Dec 24 (Print Publication: 2021).
Autor:
Kim, Geebum1 (AUTHOR) drkgb77@gmail.com, Lee, So Young2 (AUTHOR) faustina117@gilhospital.com, Oh, Seyeon3 (AUTHOR) seyeon8965@gmail.com, Jang, Jong-Won3,4 (AUTHOR) jh58333@gachon.ac.kr, Lee, Jehyuk5,6 (AUTHOR) doctorbom@gachon.ac.kr, Kim, Hyun-Seok7 (AUTHOR) khsps7799@gmail.com, Son, Kuk Hui2 (AUTHOR) dr632@gachon.ac.kr, Byun, Kyunghee3,4,5 (AUTHOR) dr632@gachon.ac.kr
Publikováno v:
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12522. 19p.